Addictions, Drug & Alcohol Institute
Addictions, Drug & Alcohol Institute > ADAI Publications

ADAI Publications

1331 publications found

  1. Dalve K, Gause E, Mills B, Floyd AS, Rivara FP, Rowhani-Rahbar A. Neighborhood disadvantage and firearm injury: does shooting location matter? Injury Epidemiology 2021;8,10. [doi: 10.1186/s40621-021-00304-2] PMID: 33678193 PMCID: PMC7938602
  2. Molfenter T, Roget N, Chaple M, Behlman S, Cody O, Hartzler B, Johnson E, Nichols M, Stilen P, Becker SJ. Use of telehealth in substance use disorder services during and after COVID-19: Online survey study. JMIR Ment Health 2021;8(2):e25835. [doi: 10.2196/25835] PMID: 33481760 PMCID: PMC7895293
  3. Schauer GL, Dilley JA, Roehler DR, Sheehy TJ, Dilley JR, Broschart SC, Holland KM, Baldwin GT, Holmes-Chavez AK, Hoots BE. Cannabis sales increases during COVID-19: Findings from Alaska, Colorado, Oregon, and Washington. International Journal of Drug Policy 2021;98:103384. [doi: 10.1016/j.drugpo.2021.103384] PMID: 34364201 PMCID: PMC9759692
  4. Roache JD, Pavlicova M, Campbell ANC, Choo T, Peavy M, Kermack AS, Nunes EV, Rotrosen J. Is extended release naltrexone superior to buprenorphine-naloxone to reduce drinking among outpatients receiving treatment for opioid use disorder? A secondary analysis of the CTN X:BOT trial. Alcohol: Clinical & Experimental Research 2021;45(12):2569-2578. [doi: 10.1111/acer.14729] PMID: 34698397 PMCID: PMC8722377
  5. van Tilburg MAL, Levy RL, Stoner S, Romano JM, Murphy TB, Abdullah B, Manci L, Feld AD. Mediation of outcomes for cognitive behavioral therapy targeted to parents of children with functional abdominal pain disorders. Journal of Psychosomatic Research 2021;150:110618. [doi: 10.1016/j.jpsychores.2021.110618] PMID: 34598050 PMCID: PMC8526395
  6. Carlini BH, Garrett SB, Firth C, Harwick R. Cannabis retail staff (“budtenders”) attitudes towards cannabis effect on health and experiences interacting with consumers – Washington State USA. Journal of Psychoactive Drugs 2022;29:1-9. [doi: 10.1080/02791072.2021.1900628] PMID: 33781175
  7. Fairlie AM, Jaffee AE, Davis KC, Litt DM, Kaysen D, Norris J, Lewis MA. Establishing a new measure of alcohol-related sexual consequences and examining its association to alcohol consequences among at-risk young adults. Journal of Studies on Alcohol and Drugs 2021;82(4):593-502. [doi: 10.15288/jsad.2021.82.493] PMID: 34343081 PMCID: PMC8356789
  8. Peavy KM, Banta-Green C, Owens M. Opioids and Stimulants: What Are They and How Are People Using Them? Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, April 2021
  9. Kingston S. WA State Project to Prevent Prescription Drug/Opioid Overdose: Final Report on Naloxone Distribution, September 1, 2016 – August 31, 2021. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, November 2021
  10. Peavy KM, Banta-Green C, Owens M. Helping People Who Use Opioids and Stimulants. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, April 2021
  11. Parker M, Duran B, Rhew I, Magarati M, Egashira L, Larimer M, Donovan DM. Prevalence of moderate and acute suicidal ideation among a national sample of tribal college and university students 2014–2015. Archives of Suicide Research 2021;25(3):406-423. [doi: 10.1080/13811118.2019.1691691] PMID: 31769351 PMCID: PMC7739486
  12. Banta-Green CJ, Williams J. Dramatic Increases in Opioid Overdose Deaths Due to Fentanyl Among Young People in Washington State. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, December 2021
  13. Rosa C, Marsch LA, Winstanley EL, Brunner M, Campbell ANC. Using digital technologies in clinical trials: Current and future applications. Contemporary Clinical Trials 2021;100:106219. [doi: 10.1016/j.cct.2020.106219] PMID: 33212293 PMCID: PMC8734581
  14. Shih RA, Tucker JS, Pedersen ER, Seelam R, Dunbar MS, Kofner A, Firth C, D'Amico EJ. Density of medical and recreational cannabis outlets: racial/ethnic differences in the associations with young adult intentions to use cannabis, e-cigarettes, and cannabis mixed with tobacco/nicotine. Journal of Cannabis Research 2021;3(1):28. [doi: 10.1186/s42238-021-00084-y] PMID: 34243820 PMCID: PMC8272320
  15. Hatch-Maillette MA, Peavy KM, Tsui JI, Banta-Green CJ, Woolworth S, Grekin P. Re-thinking patient stability for methadone in opioid treatment programs during a global pandemic: Provider perspectives. Journal of Substance Abuse Treatment 2021;124:108223. [doi: 10.1016/j.jsat.2020.108223] PMID: 33342667 PMCID: PMC8005420
  16. Firth CL, Baquero B, Berney R, Hoerster KD, Mooney SJ, Winters W. Not quite a block party: COVID-19 street reallocation programs in Seattle WA and Vancouver, BC. SSM - Population Health 2021;14:100769. [doi: 10.1016/j.ssmph.2021.100769] PMID: 33748391 PMCID: PMC7966863
  17. Newman A, Kingston S. Housing Program Staff Want More Training to Address Substance Use Among Residents. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, December 2021
  18. McDonell MG, Hirchak KA, Herron J, Lyons AJ, Alcover KC, Shaw J, Kordas G, Dirks LG, Jansen K, Avey J, Lillie K, Donovan D, McPherson SM, Dillard D, Ries R, Roll J, Buchwald D, HONOR Study Team. Effect of incentives on alcohol abstinence with three American Indian and Alaska Native communities: A multi-site randomized controlled trial. JAMA Psychiatry 2021;78(6):599-606. [doi: 10.1001/jamapsychiatry.2020.4768] PMID: 33656561 PMCID: PMC7931140
  19. Pedersen ER, Firth C, Rodriguez A, Shih RA, Seelam R, Kraus L, Dunbar MS, Tucker JS, Kilmer B, D'Amico EJ. Examining associations between licensed and unlicensed outlet density and cannabis outcomes from preopening to postopening of recreational cannabis outlets. American Journal on Addictions 2021;30(2):122-130. [doi: 10.1111/ajad.13132] PMID: 33378105 PMCID: PMC8157480
  20. Banta-Green CJ, Hansen RN, Ossiander EM, Wasserman CR, Merrill JO. Buprenorphine utilization among all Washington State residents’ based upon prescription monitoring program data – Characteristics associated with two measures of retention and patterns of care over time. Journal of Substance Abuse Treatment 2021;127:108446. [doi: 10.1016/j.jsat.2021.108446] PMID: 34049724